Ellen Hellesylt

Most-cited papers

1. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.

   A. Slipicevic, A. Holth, Ellen Hellesylt, C. Tropé +2 more

   2014Gynecologic Oncology75 citations

   Semantic Scholar

   Save

2. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.

   B. Davidson, A. Holth, Ellen Hellesylt, T. Tan +4 more

   2015Human Pathology61 citations

   Semantic Scholar

   Save

3. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.

   T. Hetland, Ellen Hellesylt, V. A. Flørenes, C. Tropé +2 more

   2011Human Pathology52 citations

   Semantic Scholar

   Save

4. High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients

   G. Magnussen, Ellen Hellesylt, J. Nesland, C. Tropé +2 more

   2013BMC Cancer46 citations Open access

   Semantic Scholar

   Save

5. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma

   B. Davidson, V. Abeler, Ellen Hellesylt, A. Holth +5 more

   2012Gynecologic Oncology41 citations Open access

   Semantic Scholar

   Save

6. VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival.

   B. Davidson, Y. B. Rosenfeld, A. Holth, Ellen Hellesylt +3 more

   2014Human Pathology18 citations

   Semantic Scholar

   Save

7. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.

   A. Slipicevic, G. F. Øy, Inger Cecilie Askildt, A. Holth +3 more

   2009Human Pathology18 citations

   Semantic Scholar

   Save

8. MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.

   B. Davidson, H. Stavnes, Ellen Hellesylt, T. Hager +3 more

   2016Human Pathology16 citations

   Semantic Scholar

   Save

9. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.

   B. Davidson, A. Holth, Ellen Hellesylt, R. Hadar +3 more

   2016Human Pathology14 citations

   Semantic Scholar

   Save

10. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma

    B. Davidson, Ellen Hellesylt, A. Holth, H. Danielsen +2 more

    2017Virchows Archiv12 citations

    Semantic Scholar

    Save

11. Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma.

    B. Davidson, Marianne Bjørnerem, A. Holth, Ellen Hellesylt +2 more

    2018Gynecologic Oncology4 citations

    Semantic Scholar

    Save

12. A novel grid polymerase chain reaction (G‐PCR) approach at ultrastructural level to detect target DNA in cell cultures and tissues

    Bilquis N. Kareem, F. Karlsen, R. Holm, E. Hennig +4 more

    1997Journal of Pathology3 citations

    Semantic Scholar

    Save

13. TGFβ splicing and canonical pathway activation in high-grade serous carcinoma

    Neriya Gutgold, B. Davidson, Liora Jacobs Catane, A. Holth +4 more

    2017Virchows Archiv2 citations

    Semantic Scholar

    Save